LDB2 and nonpapillary renal cell carcinoma: The signature included CYYR1 and LDB2 genes that have been described to be correlated with disease-free survival in synchronously vs. metachronously metastasized primary ccRCC, and in synchronous vs. metachronous metastases [30].